ES2083254T3 - Composiciones para la administracion topica de espironolactona. - Google Patents

Composiciones para la administracion topica de espironolactona.

Info

Publication number
ES2083254T3
ES2083254T3 ES93306120T ES93306120T ES2083254T3 ES 2083254 T3 ES2083254 T3 ES 2083254T3 ES 93306120 T ES93306120 T ES 93306120T ES 93306120 T ES93306120 T ES 93306120T ES 2083254 T3 ES2083254 T3 ES 2083254T3
Authority
ES
Spain
Prior art keywords
spironolactone
compositions
topic administration
lauramide
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93306120T
Other languages
English (en)
Inventor
Dario Norberto Ramon D Carrara
Francisco Jose Evarist Stefano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beta Pharmaceuticals Co
Original Assignee
Beta Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beta Pharmaceuticals Co filed Critical Beta Pharmaceuticals Co
Application granted granted Critical
Publication of ES2083254T3 publication Critical patent/ES2083254T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

UN LAURAMIDO DE N,N-DIALQUIL C1-C4, POR EJEMPLO LAURAMIDA DE N,NDIMETIL, SE UTILIZA COMO MEJORADOR DE LA PERMEABILIDAD PARA LA ESPIRONOLACTONA QUE SE APLICA TOPICAMENTE PARA SUPRIMIR UNA ACTIVIDAD ANDROGENICA INCREMENTADA DE LA PIEL Y PARA TRATAR ENFERMEDADES DE LA PIEL RELACIONADAS CON LA ACTIVIDAD HIPERANDROGENICA.
ES93306120T 1992-08-06 1993-08-03 Composiciones para la administracion topica de espironolactona. Expired - Lifetime ES2083254T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92656192A 1992-08-06 1992-08-06

Publications (1)

Publication Number Publication Date
ES2083254T3 true ES2083254T3 (es) 1996-04-01

Family

ID=25453377

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93306120T Expired - Lifetime ES2083254T3 (es) 1992-08-06 1993-08-03 Composiciones para la administracion topica de espironolactona.

Country Status (6)

Country Link
EP (1) EP0582458B1 (es)
AT (1) ATE130515T1 (es)
DE (1) DE69300854T2 (es)
DK (1) DK0582458T3 (es)
ES (1) ES2083254T3 (es)
MX (1) MX9303557A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599548A (en) * 1995-05-08 1997-02-04 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides and retinol or retinyl ester
US5716627A (en) * 1996-04-25 1998-02-10 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides, azoles, and retinol or retinyl ester
US5693330A (en) * 1996-04-25 1997-12-02 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing melinamide and a retinoid
US5747051A (en) * 1996-09-27 1998-05-05 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing an amide of a hydroxy fatty acid and a retinoid
US5955092A (en) * 1996-09-27 1999-09-21 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing an n-substituted fatty acid amide and retinol or retinyl ester
DE19843784A1 (de) * 1998-09-24 2000-04-20 Temic Semiconductor Gmbh Schaltungsanordnung zur Leistungsverstärkung
AU5460800A (en) * 1999-06-02 2000-12-18 Aviana Biopharm Pharmaceutical transdermal compositions
US9241944B2 (en) * 2010-06-16 2016-01-26 Institut National De La Santé Et De La Recherche Médicale (Inserm) Methods and compositions for stimulating reepithelialisation during wound healing
US10350223B2 (en) 2015-03-03 2019-07-16 Richard W. Yee Compositions and methods for treating ocular diseases
US11524016B2 (en) 2020-07-17 2022-12-13 Amy Thorne Compositions and methods for the topical administration of spironolactone for the treatment of cutaneous signs of excess androgen and chronic stress response

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI59534C (fi) * 1979-10-31 1981-09-10 Orion Yhtymae Oy Vaordmedel foer fraemjande av haorvaext och hindrande av mjaell
US4347245A (en) * 1981-05-26 1982-08-31 German Shapiro Spironolactone-containing composition and use thereof
IT1194185B (it) * 1983-04-01 1988-09-14 Schiapparelli Farma Composizione per il trattamento dell'acne
FR2588755B3 (fr) * 1985-10-21 1988-01-22 Aron Brunetiere Robert Composition therapeutique a base de spironolactone destinee au traitement des alopecies androgenogenetiques
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
EP0410348A1 (en) * 1989-07-26 1991-01-30 G.D. Searle & Co. Topical spironolactone composition
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices

Also Published As

Publication number Publication date
DK0582458T3 (da) 1996-04-09
EP0582458B1 (en) 1995-11-22
DE69300854D1 (de) 1996-01-04
DE69300854T2 (de) 1996-06-05
MX9303557A (es) 1994-03-31
ATE130515T1 (de) 1995-12-15
EP0582458A1 (en) 1994-02-09

Similar Documents

Publication Publication Date Title
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
AU580056B2 (en) Dentifrice compositions
ES2052682T3 (es) Una composicion farmaceutica potenciadora de la penetracion para aplicacion topica.
TW283645B (es)
MX9704735A (es) Formulaciones para reducir irritacion de la piel y el uso de las mismas.
ES2083254T3 (es) Composiciones para la administracion topica de espironolactona.
MX9703693A (es) Tratamiento profilactico de dermatitis alergica por contacto.
AU2999695A (en) Alcoholic moisturizing after shave lotion
AU571003B2 (en) Scalp treatment by lipase application
EP0727987A4 (en) INHIBITION OF THE BREATHING SALVE USING POSTTRANSLATIONAL MODIFICATION INHIBITORS RELATING TO MODIFICATION
TWI256892B (en) Plasminogen activator inhibitor and external preparation for skin comprising the same
ES8701193A1 (es) Un procedimiento para preparar derivados de acido griseolico
IL106288A0 (en) Skin regenerating cosmetic compositions
GR3025872T3 (en) Orally active derivatives of 1,3,5(10)-estratriene
EP0028525A3 (en) Hair treatment agent promoting the growth of hair and preventing dandruff
EP0451869A3 (en) Use of steroid derivatives in the treatment of endometriosis
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
ES2121109T3 (es) Composicion de champu.
EP0521080A4 (en) Synergistic compositions
IL107242A0 (en) Derivatives of benzeneborinic acid, preparation thereof and use thereof as synthetic intermediates
EP0992242A4 (en) PROPHYLACTIC AGENTS AND / OR REMEDIES CONTAINING VITAMIN D FOR PREVENTING AND / OR TREATING CONJUNCTIVAL / CORNEAL XEROSIS
EP0448726A4 (en) 2-substituted 2-cyclopentenone and carcinostatic agent and osteogenesis promoter containing the same as active ingredient
ES453237A1 (es) Un procedimiento para la produccion de una preparacion anti-hipertensiva.
MY108690A (en) Mildewproofing agent for timber
TW225993B (en) A composition prevention hair loss and promoting hair growth and its usage

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 582458

Country of ref document: ES